# PErfusioN, OxyGen ConsUmptIon and ENergetics in ADPKD (PENGUIN)

> **NCT04407481** · — · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 22 (actual)

## Conditions studied

- Polycystic Kidney Disease, Adult
- Polycystic Kidney, Autosomal Dominant

## Interventions

- **DRUG:** Aminohippurate Sodium Inj 20%
- **DRUG:** Iohexol Inj 300 milligrams per milliliter (MG/ML)
- **RADIATION:** PET/CT Scan

## Key facts

- **NCT ID:** NCT04407481
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-01
- **Primary completion:** 2022-10-13
- **Final completion:** 2022-10-13
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2023-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04407481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04407481, "PErfusioN, OxyGen ConsUmptIon and ENergetics in ADPKD (PENGUIN)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04407481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*